机构:[a]Clinical Laboratory, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou, Jiangsu 215004, China[b]Institute of Life Sciences, Jiangsu University, 301 Xuefu Road, Zhenjiang, Jiangsu 212013, China[c]Pathogen Diagnostic Center, Institut Pasteur of Shanghai, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200025, China[d]Xiangcheng District Center of Disease Control and Prevention, 55 Yangchenghu Road, Suzhou, Jiangsu 215131, China[e]Zhenjiang Center of Disease Control and Prevention, 9 Huangshan South Road, Zhenjiang, Jiangsu 212001, China
Background: HCV transmission is closely associated with injection drug use (IDU), and co-circulation of multiple subtypes has been found among injection drug users (IDUs) in China. Objectives: To investigate HCV subtype characterizations among IDUs and general population (GP) in Suzhou, a city at the important "Hu-ning" transportation line. Study design: During January 2010 to May 2011, 123 HCV positive plasma from IDUs and 131 stored HCV positive sera from general individuals were collected in Suzhou. HCV C/E2 and NS5B fragments were amplified using a new multiple RT-nested PCR strategy and subsequent sequenced. Genotypes were characterized by phylogenetic analyses. Results: Eight HCV subtypes (1a, 1b, 2a, 3a, 3b, 6a, 6n, and 6u) were detected among Suzhou IDUs, and six subtypes (1b, 2a, 3a, 3b, 6a and 6n) among GP. HCV subtype distribution is distinct between IDUs and GP. Interestingly, we detected discrepancy of genotyping results between C/E2 and NS5B regions in one general individual, indicating the presence of HCV intersubtype recombinant in China. The recombinant belongs to a 3a/1b recombinant. We also detected dual infections in one general individual and two IDUs. They include dual infections between 1b and 3a, 3a and 6a, and two distinct lineages of 3b. Conclusions: Complex patterns of HCV epidemic among IDUs, as well as GP, in Suzhou, might imply a spread of HCV from IDUs to GP. The finding of one HCV 3a/1b intersubtype recombinant might represent the first report of HCV recombination in China. (C) 2012 Elsevier B. V. All rights reserved.
基金:
the startup fund of Institut Pasteur of Shanghai, CAS, the Natural Science Foundation of Jiangsu
Province, China (No. BK2011474) and the National Natural Science Foundation of China (No. 81071391) , and the Professional
Research Foundation for Back-up academic leaders of the Second Affiliated Hospital of Soochow University
第一作者机构:[a]Clinical Laboratory, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou, Jiangsu 215004, China
共同第一作者:
通讯作者:
通讯机构:[a]Clinical Laboratory, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou, Jiangsu 215004, China[*]Pathogen Diagnostic Center, Institute Pasteur of Shanghai, Chinese Academy of Sciences, 411 Hefei Road, Shanghai 200025, China.
推荐引用方式(GB/T 7714):
Hong Du,Yinle Qi,Fangyuan Hao,et al.Complex patterns of HCV epidemic in Suzhou: Evidence for dual infection and HCV recombination in East China[J].JOURNAL OF CLINICAL VIROLOGY.2012,54(3):207-12.doi:10.1016/j.jcv.2012.04.017.
APA:
Hong Du,Yinle Qi,Fangyuan Hao,Yan Huang,Lingxiang Mao...&Chiyu Zhang.(2012).Complex patterns of HCV epidemic in Suzhou: Evidence for dual infection and HCV recombination in East China.JOURNAL OF CLINICAL VIROLOGY,54,(3)
MLA:
Hong Du,et al."Complex patterns of HCV epidemic in Suzhou: Evidence for dual infection and HCV recombination in East China".JOURNAL OF CLINICAL VIROLOGY 54..3(2012):207-12